TN-C, mainly produced by cardiac fibroblasts, is also released into the bloodstream in the course of a wide range of cardiac disease conditions in humans, and used as a biomarker predicting the degree of cardiac remodeling and subsequent mortality in patients (14–17, 21). The gene discussed is TNC; the disease is heart disorder.